Seeking Alpha

Stryker Biotech, a Stryker Corp. (SYK -0.9%) unit, pleaded guilty to misbranding a medical...

Stryker Biotech, a Stryker Corp. (SYK -0.9%) unit, pleaded guilty to misbranding a medical device during its trial over charges it marketed an unapproved mixture of products for strengthening human bone growth. The guilty plea means Stryker Corp. CEO Stephen MacMillan won't have to testify. Stryker will also pay a $15M fine. (submitted by Holly Thompson)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs